ALEMBIC DEFERASIROX deferasirox 360 mg film-coated tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

deferasirox, Quantity: 360 mg

Tilgjengelig fra:

Alembic Pharmaceuticals Australia Pty Ltd

Legemiddelform:

Tablet, film coated

Sammensetning:

Excipient Ingredients: colloidal anhydrous silica; magnesium stearate; crospovidone; sodium starch glycollate type A; microcrystalline cellulose; poloxamer; povidone; titanium dioxide; hypromellose; purified talc; macrogol 4000; indigo carmine aluminium lake

Administreringsrute:

Oral

Enheter i pakken:

30

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

The treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. ALEMBIC DEFERASIROX is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. ,ALEMBIC DEFERASIROX is also indicated for the treatment of chronic iron overload in patients with non-transfusion- dependent thalassemia syndromes aged 10 years and older.

Produkt oppsummering:

Visual Identification: Dark blue, oval, biconvex, film-coated tablet with beveled edges, debossed with "L" on one side and "665" on the other side. Approximately 17 mm in length and approximately 7 mm in width.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisasjon status:

Registered

Autorisasjon dato:

2020-11-16